This suggests that HOXC8 may have a role in both the acquisition of the invasive and metastatic phenotype of this malignancy as well as in inhibiting androgen responsive prostate cancer cells (Waltregny et al, 2002; Miller et al, 2003). This evidence concerns the gene HOXC8 and prostate carcinoma.